Skip to content

Microneedling in androgenetic alopecia

Comparative efficacy study of microneedling (2 different depth of penetration) and topical minoxidil versus topical minoxidil alone in androgenetic alopecia in patients referring to educational center of Isfahan university of medical sciences

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191203045592N1
Enrollment
60
Registered
2020-01-03
Start date
2018-04-21
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenetic alopecia. Androgenic alopecia

Interventions

Intervention 1: Control group: Use 1 CC of topical 5% minoxidil lotion (Pakdarou co., Tehran, Iran) applied twice daily for 12 weeks. Intervention 2: Intervention group no.1: Use 1 CC of topical 5% mi

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Patients with moderate to severe androgenetic alopecia Patients who have not used systemic medications that influence hair growth within the past 6 months

Exclusion criteria

Exclusion criteria: Patients with other forms of alopecia, such as telogen effluvium and alopecia areata Patients with history of bleeding disorders Patients with keloidal tendency Patients with active infection at the microneedling site Patients with skin dermatosis with risk of Koebner phenomenon, such as psoriasis and lichen planus Pregnant and lactating women Patients with any major systemic disease

Design outcomes

Primary

MeasureTime frame
Hail count. Timepoint: At start of study and 14 weeks. Method of measurement: Scalp & Hair Polarizing HMS System (KC Technology Company; Korea).;Hair thickness. Timepoint: At start of study and 14 weeks. Method of measurement: Scalp & Hair Polarizing HMS System (KC Technology Company; Korea).;Patient's satisfaction score. Timepoint: At 14 weeks. Method of measurement: The standardized 7 point rating scale (–3 = greatly decreased, –2 = moderately decreased, –1 = slightly decreased, 0 = no change, +1 = slightly increased, +2 = moderately increased, +3 = greatly increased).;Investigator's assessment based on changes in standard photographs. Timepoint: Standard photography at base line and at 14 weeks. Method of measurement: The standardized 7 point rating scale (–3 = greatly decreased, –2 = moderately decreased, –1 = slightly decreased, 0 = no change, +1 = slightly increased, +2 = moderately increased, +3 = greatly increased).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamin Nabavinejad

Esfahan University of Medical Sciences

saminstrs@gmail.com+98 31 3131 7715

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026